Rotate Back To Portrait
This CareHub page is optimized for portrait viewing on mobile. Desktop version provides the full viewing experience.
Esta pagina de CareHub esta optimizada para verse en vertical en movil. La version de escritorio ofrece la experiencia de visualizacion completa.
Cette page CareHub est optimisee pour un affichage mobile en mode portrait. La version ordinateur offre l'experience de visualisation complete.
Award Program
Honoring Courage, Celebrating Resilience, Recognizing Excellence
2026 Launch Budget
Enterprise-linked year-one awards range using the current conservative to aggressive 2026 ARR scenarios.
2026-2030 Capacity
Direct awards capacity across the first five operating years, tied to the updated enterprise forecast.
Emotional Value Floor
Conservative 10-year mental health, reduced isolation, and blockchain-preserved inspiration value.
Who Is Recognized
The program is built to honor every part of the care equation, not one role in isolation.
The Care Gap Crisis
The universal care gap crisis extends across all chronic diseases. Patients with Cancer, Alzheimer's, Autism, Parkinson's, Long COVID, Obesity, Type II Diabetes, and Aged Care all face elevated depression, anxiety, burnout, and isolation.
The Award Program recognizes and celebrates the extraordinary courage of warriors, the unwavering dedication of their caregivers, and the healthcare providers delivering exceptional care. It combines meaningful rewards with permanent blockchain commemoration so support, visibility, and legacy are built into the model from the start.
Our Solution: Starting with Cancer warriors and caregivers to prove the model, recognition through awards provides validation, reduces isolation, connects warriors to community support, and creates permanent blockchain-preserved testimonials that inspire thousands globally.
This model combines immediate financial relief, reduced isolation, global inspiration, and long-term societal value while scaling across all 8 chronic disease communities.
Financial Awards Scale with Success: The 2026 enterprise forecast spans $10.8M-$22.8M ARR, which implies a launch-year awards budget range of roughly $6.3K-$13.3K while maintaining the same award-intensity ratio.
Transformational Impact
- Immediate Relief: Financial awards provide critical support for treatment costs, living expenses, and emergency needs
- Mental Health Support: Recognition reduces depression, anxiety, and isolation through community connection
- Family Support: Caregivers receive validation and relief from the invisible burden they carry
- Global Inspiration: Blockchain-preserved stories inspire countless others facing similar battles worldwide
- Lasting Legacy: Permanent commemoration ensures courage is never forgotten
Built for Sustainability
Long-Term Sustainability Features
- 4% Total Token Allocation: Streamlined model focused on high-impact annual awards plus quarterly creative recognition
- Indefinite Program Duration: Pre-IPO uses token reserve; post-IPO switches to cash awards funded by revenue buyback mechanisms
- No Additional Dilution: Post-IPO awards are funded from operating cash flow, not new token issuance
- Governance-Driven Expansion: Token holders vote on timing and allocation for each new disease community
- Inflation Buffer: Allocation includes cushion given token appreciation outpaces CPI in growth scenarios
Sustainable Funding Model
The program is designed to operate indefinitely through enterprise revenue and treasury discipline.
Funding Sources
- Buyback Program: Enterprise revenues continuously replenish the award pool
- Token Appreciation: Fewer tokens are needed over time to maintain target award values
- Reserve Discipline: Treasury structure preserves long-run purchasing power
Governance and Transparency
Community-Driven Decisions: Token holders vote on award amounts, new disease community additions, and expansion timing so the model scales in step with proof of impact.
Program Architecture at a Glance
Awards Structure
Streamlined high-impact model per disease community:
- 3 Year 1 Annual Awards: one annual award for Alzheimer's, one for Cancer, and one for Long COVID
- 4 Quarterly Creative Awards: cross-condition Child, Teen, Young Adult, and Adult categories
- Commemorative NFTs: All winners receive permanent blockchain recognition
- Total launch plan: $8,750 in the moderate 2026 case across Alzheimer's, Cancer, and Long COVID, expanding to all 8 conditions by Q3 2027
Provider Recognition Pathway
Recognizing exceptional healthcare delivery and innovation across the care continuum remains part of the broader awards architecture.
As enterprise-linked capacity expands beyond the initial Alzheimer's, Cancer, and Long COVID rollout, provider recognition can honor physicians, healthcare systems, aged care centers, pharmaceutical companies, AI healthcare providers, and other entities making measurable impact through innovative care delivery, patient support programs, product and service sponsorships, or breakthrough research.
- Physicians: Specialists demonstrating exceptional patient care and compassion
- Healthcare Systems: Hospitals or clinics implementing breakthrough care models
- Aged Care Centers: Facilities providing dignity-focused chronic disease management
- Pharmaceutical Companies: Organizations advancing research or accessibility
- AI Healthcare Providers: Technology companies delivering diagnostic or care-coordination innovation
- Other Healthcare Entities: Labs, imaging centers, home health agencies, and support organizations
Phased Expansion Timeline
- Q2 2026: Cancer launch
- Q2 2026: Long COVID
- Q3 2026: Alzheimer's
- Q1 2027: Obesity and Type II Diabetes
- Q2 2027: Autism
- Q3 2027: Aged Care and Parkinson's
Technology and Support
Blockchain Stories
Video creation preserves testimonials permanently, creating a global inspiration library accessible to anyone, anywhere, forever.
Recipient Support Services
- Wallet Setup Assistance: One-on-one guidance for non-crypto users
- Liquidation Guides: Step-by-step conversion to USDC or USD
- Tax Reporting Help: Documentation and guidance for compliance
- 24/7 Support: Dedicated help for recipients
Award Values
| Award Type | ICO Value | Token Amount |
|---|---|---|
| Community Engagement | $100 | ~11,400 CareTokens |
| Monthly Recognition | $1,000 | ~114,000 CareTokens |
| Annual Recognition | $5,000 | ~571,000 CareTokens |
Values scale with token appreciation as the platform grows.
Mental Health Benefits
Receiving recognition through an award is not just ceremonial. For patients, caregivers, survivors, and providers, formal acknowledgment can interrupt the emotional invisibility that so often builds around chronic illness and long-term care. It tells people that their effort, fear, resilience, and contribution have been seen by others and are worthy of public respect.
That matters because morale is not a soft extra in chronic disease. Higher morale can support hope, identity, confidence, and willingness to stay engaged with treatment, caregiving, advocacy, and community life. Recognition also creates a social signal: you are not carrying this alone, and your story has value beyond the hardest day you are living through.
Across cancer and palliative-care literature, stronger social support is consistently associated with better quality of life, resilience, and psychological well-being, while dignity-focused interventions have shown benefits for hope, meaning, and emotional outcomes in advanced illness. That is why awards can function as more than prizes. At their best, they become structured moments of validation, morale repair, and community connection.
Key Benefits
- Validation and Recognition: Awards formally acknowledge courage, labor, and resilience that often go unseen in day-to-day care journeys.
- Morale Boost: Recognition can lift confidence, strengthen hope, and help people feel that their fight or service genuinely matters.
- Reduced Isolation: Public acknowledgment connects recipients to a wider community that sees, respects, and remembers their contribution.
- Sense of Purpose: Awards can help transform suffering and effort into meaning, identity, and legacy beyond the illness itself.
- Inspiration to Others: Recognized stories give other families and patients evidence that courage, care, and survival deserve to be honored.
Selected Evidence Base
Social support and quality of life: Luszczynska et al. found that social support is meaningfully associated with quality-of-life indicators in lung cancer patients (Psychooncology, 2013; PMID: 23097417).
Resilience, hope, and support: Sihvola et al. reported that resilience in colorectal cancer patients is associated with social support, hope, and quality of life (Eur J Oncol Nurs, 2022; PMID: 34844135).
Dignity-focused interventions: Meta-analyses of dignity therapy in advanced cancer and palliative care report benefits for hope, psychological well-being, dignity, and quality of life (Li et al., Depress Anxiety, 2020; PMID: 31808977; Xiao et al., Psychooncology, 2019; PMID: 31243850; Zhang et al., Int J Nurs Stud, 2022; PMID: 35635908).
Blockchain Preservation of Stories
Capturing these stories in video format and preserving them on the blockchain creates a permanent, globally accessible testament to their experiences that transcends traditional boundaries.
Why Blockchain?
- Permanent Record: Stories preserved forever, immune to censorship or deletion
- Global Accessibility: Anyone, anywhere can access these narratives
- Personalized Stories: Video creation ensures each story is unique
- Democratized Access: No geographic or socioeconomic barriers
- Inspiration at Scale: Wisdom shared with countless others facing similar battles
Total Societal Value: Financial + Emotional Impact
This program creates value far exceeding direct financial awards. By combining tangible token rewards with profound emotional and mental health benefits, the Award Program delivers extraordinary societal value over time.
Dual-Impact Design: Recipients receive tangible awards that provide immediate liquidity for critical needs, while their blockchain-preserved stories create exponential emotional value by inspiring countless others facing similar battles.
2026 Launch Funding Sensitivity
The current enterprise page now models 2026 ARR at $10.8M in the conservative case, $15M in the moderate case, and $22.8M in the aggressive case. Holding the awards program at the same launch intensity puts the year-one funding envelope at roughly $6.3K-$13.3K, with the current $8.75K Alzheimer's, Cancer, and Long COVID rollout still matching the moderate case.
Enterprise-Linked Planning Snapshot
- 2026 Launch Budget: $6.3K-$13.3K across conservative to aggressive enterprise scenarios
- 2026-2030 Direct Awards Capacity: $1.12M-$2.19M using the same 0.0583% launch-intensity ratio
- Emotional and Mental Health Value: $2.6M+ as a conservative 10-year floor
- Multi-Disease Expansion: Scales from the Alzheimer's, Cancer, and Long COVID rollout to all 8 disease and condition communities by Q3 2027
Calculating Emotional Value in Dollar Terms
We use a health economics approach to quantify the monetary value of non-financial outcomes including mental health improvements, reduced isolation, and quality-of-life gains.
Per-Recipient Emotional Value: $5,000
1. Mental Health Treatment Costs Avoided: $2,000-$3,000
- Recognition reduces depression and anxiety
- Saves therapy sessions and medication needs
- Improves treatment compliance and outcomes
2. Reduced Isolation Value: $1,000-$1,500
- Connection to community
- Improved quality of life
- Reduced readmissions and better health outcomes
3. Family Impact: $1,500
- Reduced caregiver burden
- Lower family anxiety and stress
- Reduced burnout
4. Community Inspiration: Exponential Growth
- Each blockchain story can be viewed by 100 to 500 people per year
- Each viewer gains measurable inspiration and hope value
- Permanent preservation ensures lasting impact
Conservative Methodology
Our $5,000 per-recipient estimate is deliberately modest. Actual mental health treatment for chronic disease patients often costs substantially more. We use conservative figures to keep projections defensible while still showing the scale of impact.
Sources and Methodology Notes
Clinical evidence base: The morale, hope, social-support, and dignity claims on this page are grounded in the literature cited in Mental Health Benefits, including Luszczynska et al. (Psychooncology, 2013; PMID: 23097417), Sihvola et al. (Eur J Oncol Nurs, 2022; PMID: 34844135), and dignity-therapy meta-analyses (PMIDs: 31808977, 31243850, 35635908).
Economic framing: The $5,000 per-recipient emotional-value proxy is a conservative planning estimate, not a formal cost-effectiveness or QALY model. It is built from modest ranges for avoided mental-health support costs, reduced isolation burden, caregiver spillover benefits, and downstream inspiration value from permanently accessible stories.
Forecast basis: The launch-budget, 2026-2030 capacity, and scaling examples below are derived from the current enterprise scenario framework: 2026 ARR of $10.8M, $15M, and $22.8M; 2027 moderate ARR of $130M; 2028 moderate ARR of $400M with an illustrative $4.0B valuation; and 2030 scenarios of $830M+, $1.3B, and $1.67B ARR.
Application rule: Awards budgets are calculated by applying the current moderate launch ratio of 0.0583% of ARR, based on the present $8.75K plan on $15M ARR, across the relevant enterprise milestones.
Enterprise-Linked Awards Capacity
The table below replaces the old placeholder market-cap scenarios with values tied directly to the enterprise forecast. It keeps the same launch intensity as the current $8.75K moderate 2026 plan, which allocates 0.0583% of ARR to the awards program.
| Scenario | 2026 ARR | 2028 IPO Valuation | 2026-2030 Direct Awards Capacity | Planning Read |
|---|---|---|---|---|
| Conservative | $10.8M | $2.9B | $1.12M | Supports a disciplined Alzheimer's, Cancer, and Long COVID rollout with measured expansion. |
| Moderate | $15M | $4.0B | $1.53M | Matches the current $8.75K launch plan and gives room for multi-disease expansion. |
| Aggressive | $22.8M | $5.6B | $2.19M | Creates headroom for faster expansion and materially larger annual award pools. |
Method: 2026-2030 direct awards capacity applies the current launch intensity of 0.0583% of ARR to each enterprise scenario from 2026 through 2030, then sums those annual budgets.
Source basis: enterprise scenario milestones are taken from the current Enterprise and Value Proposition planning pages, including the 2028 illustrative 10x ARR valuation framework.
The warrior awards program delivers a comprehensive mental health intervention, financial support system, and permanent tribute to human resilience, powered by sustainable tokenomics.
Token Economy Integration
This initiative celebrating warriors and caregivers serves as a key driver for CareToken™. By creating blockchain-preserved video testimonials, each recognition award generates authentic content that increases token utility and ecosystem value.
Economic Model Benefits
- Rewards Warriors Directly: Recipients receive meaningful token allocations
- Supports Community: The broader ecosystem benefits from increased engagement
- Creates Value: Authentic stories drive platform growth and token utility
- Network Expansion: Visibility attracts new participants and stakeholders
- Virtuous Cycle: Recognition strengthens both individuals and the platform
Token Allocation Structure
A sustainable model that allows award recipients to liquidate at any time while maintaining token value requires careful token allocation structure. As the platform grows and proves success with the Alzheimer's, Cancer, and Long COVID rollout, the model expands to additional disease communities.
Initial Assumptions
Year 1 Alzheimer's, Cancer & Long COVID: 1 annual per condition, plus 4 quarterly cross-condition creative awards totaling $8,750 in the moderate 2026 case
Total Token Supply: 500 million tokens
Total Award Reserve: 4% of supply or 20 million tokens
Moderate 2026 Rollout Allocation: Approximately 1 million tokens for the initial Alzheimer's, Cancer, and Long COVID launch plan
Multi-Disease Expansion Model
Scalable Allocation Strategy
Q2 2026: Cancer launch
Q3 2026: Long COVID
Q4 2026: Alzheimer's
Q1 2027: Obesity and Type II Diabetes
Q2 2027: Autism
Q3 2027: Aged Care and Parkinson's
Token Reserve Allocation
| Component | Allocation | Details |
|---|---|---|
| Total Award Reserve | 4% (20M tokens) | Award pool with inflation protection built in |
| Moderate 2026 Rollout | ~0.2% (1M tokens) | Funds the Alzheimer's, Cancer, and Long COVID launch plan at the current moderate 2026 budget. |
| Future Expansion Reserve | ~3.8% (19M tokens) | Reserved for additional disease communities, larger future annual pools, and inflation protection. |
| Per Award Value | 114K to 571K tokens | $1,000 to $5,000 at ICO price |
| Sustainability | Indefinite | Buyback mechanism plus enterprise revenue |
Long-Term Sustainability Features
- Inflation Protection Built In: Treasury structure maintains purchasing power over time
- Buyback Program: Enterprise revenues continuously replenish the award pool
- Token Appreciation: Fewer tokens are needed as platform value grows
- No Additional Dilution: Awards are funded from operating cash flow
Implementation Structure
Time-Locked Treasury
Dedicated Multi-Sig Wallet
Create a secure multi-signature wallet holding the 4% warrior allocation, ensuring no single person can unilaterally access funds.
Quarterly Release Schedule
- Q1: 1 quarterly creative award distributed
- Q2: 1 quarterly creative award distributed
- Q3: 1 quarterly creative award distributed
- Q4: 1 quarterly creative award plus 3 annual awards
Liquidation Mechanics
Recipient Support System
- Private Wallet Setup Assistance: One-on-one guidance for wallet creation and security
- Major Awards: 50% immediate, 50% vested over 3 months
- Smaller Awards: 100% immediate release
- Liquidation Guides: Exchange, tax, and support documentation
Long-Term Sustainability
Token Buyback Mechanism
Buyback Allocation: Establish ongoing token buyback using enterprise revenues from day one.
Replenishment Fund: Purchased tokens are redirected to the warrior award treasury for indefinite continuation.
Governance Proposals
Community-Driven Decisions: Token holders can vote on award amounts, new categories, and geographic expansion through governance proposals.
Key Balancing Factors
This structure balances several critical factors to ensure program success and sustainability.
Design Principles
1. Recipient Flexibility
Recipients can liquidate when needed or choose to reinvest in the fund while benefiting from token appreciation.
2. Market Stability
Staggered releases and quarterly distributions reduce shock from simultaneous selling.
3. Program Perpetuity
The program can continue indefinitely through buybacks, enterprise revenue, and governance-approved adjustments.
4. Reasonable Dilution
Total dilution remains controlled over time, maintaining token holder confidence.
5. Meaningful Impact
Award values from $100 to $5,000 provide meaningful support while maintaining token value stability.
Awards Budget Scaling Examples
| Milestone | Forecast Input | Implied Annual Awards Budget | What It Supports |
|---|---|---|---|
| 2026 Conservative Launch | $10.8M ARR | $6.3K | Supports the same 3 annual awards plus 4 quarterly cross-condition creative awards, with tighter launch-year sizing. |
| 2026 Moderate Launch | $15M ARR | $8.75K | Current planning baseline for the Alzheimer's, Cancer, and Long COVID rollout. |
| 2026 Aggressive Launch | $22.8M ARR | $13.3K | Preserves the launch structure while creating room for higher award values and stronger recipient support. |
| 2027 Full-Platform Moderate | $130M ARR | $75.8K | Once all 8 disease and condition communities are live, the annual pool can broaden meaningfully across patients, caregivers, survivors, and future provider pathways. |
| 2028 Moderate IPO Window | $400M ARR / $4.0B valuation | $233K | Supports a robust cross-condition awards calendar with materially larger annual recognition pools. |
| 2030 Conservative Scale | $830M+ ARR | $484K+ | Funds a durable multi-community program while keeping treasury assumptions conservative. |
| 2030 Moderate Scale | $1.3B ARR | $758K | Creates room for flagship awards, caregiver relief grants, and deeper storytelling preservation. |
| 2030 Aggressive Scale | $1.67B ARR | $974K | Provides major headroom for larger annual pools without changing the baseline allocation ratio. |
Method: Each example keeps the same award-intensity ratio as the current moderate 2026 plan: $8.75K on $15M ARR, or 0.0583%, applied to the live enterprise forecast milestones.
Source basis: 2027, 2028, and 2030 forecast anchors follow the current scenario tables on the Enterprise page and the synced assumptions on Value Proposition.
Citations
This section consolidates the clinical literature and planning-source links referenced throughout the awards page.
Clinical Literature
- Luszczynska et al., 2013: Social support and quality of life in lung cancer patients. PubMed PMID 23097417
- Sihvola et al., 2022: Resilience, hope, and social support in colorectal cancer patients. PubMed PMID 34844135
- Li et al., 2020: Meta-analysis of dignity therapy in advanced cancer and palliative settings. PubMed PMID 31808977
- Xiao et al., 2019: Dignity therapy evidence synthesis for psychological and quality-of-life outcomes. PubMed PMID 31243850
- Zhang et al., 2022: Meta-analysis of dignity-focused interventions in palliative and cancer care. PubMed PMID 35635908
Planning and Forecast Sources
- Enterprise Forecast: Source for 2026, 2027, 2028, and 2030 ARR scenario anchors, plus the illustrative 10x ARR valuation framework. Open Enterprise Page
- Value Proposition: Source for synced year-one award structure and investor-facing framing of the awards program. Open Value Proposition Page
- Awards Methodology Notes: See the Societal Value section on this page for the conservative emotional-value proxy and award-intensity ratio logic.
- Mental Health Benefits Evidence Box: See the Mental Health Benefits section on this page for the inline morale, resilience, dignity, and social-support literature summary.